Clinical trial
Randomized Controlled Trial Comparing the Metabolic Efficiency of Allogeneic Pancreatic Islet Transplantation to Intensive Insulin Therapy for the Treatment of Type 1 Diabetes
NCT01148680 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial Comparing the Metabolic Efficiency of Allogeneic Pancreatic Islet Transplantation to Intensive Insulin Therapy for the Treatment of Type 1 Diabetes
- Lead sponsor
- University Hospital, Grenoble
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- September 30, 2018
- Enrollment
- 50 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.